Julianne Chen Selected Research

Julianne Chen Research Topics

Disease

19	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 12/2011
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2023 - 03/2013
9	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2024 - 05/2015
7	Leukemia 10/2023 - 04/2015
7	Neoplasms (Cancer) 10/2017 - 04/2005
6	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 05/2015
4	Residual Neoplasm 01/2020 - 01/2017
3	Myeloid Leukemia (Leukemia, Myelocytic) 10/2023 - 11/2015
2	Weight Gain 01/2020 - 12/2017
2	Infections 01/2018 - 05/2015
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2016 - 01/2016
1	COVID-19 12/2023
1	Chronic Disease (Chronic Diseases) 10/2023
1	Idiopathic Noncirrhotic Portal Hypertension 01/2020
1	Ascites 01/2020
1	Portal Hypertension 01/2020
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Viremia 01/2018
1	Human Influenza (Influenza) 07/2015
1	Virus Diseases (Viral Diseases) 07/2015
1	Acute Promyelocytic Leukemia 08/2013
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2013
1	Glioma (Gliomas) 04/2005
1	Brain Neoplasms (Brain Tumor) 04/2005

Drug/Important Bio-Agent (IBA)

11	Busulfan (Busulfex)FDA Link 01/2022 - 06/2013
10	fludarabineIBA 01/2022 - 06/2013
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2024 - 06/2013
5	Melphalan (Alkeran)FDA LinkGeneric 01/2018 - 06/2013
3	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 06/2013
2	Clofarabine (Clolar)FDA Link 01/2022 - 10/2016
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 11/2016
2	plerixafor FDA Link 01/2019 - 07/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019 - 07/2015
2	AntigensIBA 01/2016 - 07/2015
1	Vorinostat FDA Link 01/2022
1	AlbuminsIBA 01/2020
1	Core Binding Factors (Core-Binding Factor)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Pentostatin (Nipent)FDA LinkGeneric 01/2018
1	SteroidsIBA 01/2018
1	interleukin-21 (interleukin 21)IBA 10/2017
1	fms-Like Tyrosine Kinase 3IBA 04/2017
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2016
1	NucleosidesIBA 10/2016
1	Complement System Proteins (Complement)IBA 10/2016
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 07/2015
1	Guanosine Diphosphate Fucose (GDP Fucose)IBA 05/2015
1	FucosyltransferasesIBA 05/2015
1	EnzymesIBA 05/2015
1	Calcineurin InhibitorsIBA 05/2015
1	Minor Histocompatibility AntigensIBA 04/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2014
1	ArsenicIBA 08/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2013
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 06/2013
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 12/2011
1	Sorafenib (BAY 43-9006)FDA Link 12/2011
1	Platelet-Derived Growth FactorIBA 04/2005
1	matrigelIBA 04/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2005
1	Conditioned Culture MediaIBA 04/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2005
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2005
1	Epidermal Growth Factor (EGF)IBA 04/2005
1	Chemokine CXCL12IBA 04/2005

Therapy/Procedure

16	Transplantation 10/2023 - 06/2013
15	Stem Cell Transplantation 03/2024 - 12/2011
14	Hematopoietic Stem Cell Transplantation 01/2022 - 12/2011
5	Cell Transplantation 12/2023 - 01/2016
5	Therapeutics 01/2018 - 04/2005
3	Drug Therapy (Chemotherapy) 01/2020 - 07/2015
2	Haploidentical Transplantation 01/2018 - 12/2017
1	Catheters 01/2020
1	Aftercare (After-Treatment) 10/2016
1	Blood Component Removal (Apheresis) 01/2016
1	Injections 04/2005